Utilization and Challenges of Continuous Glucose Monitoring in Sensor-Augmented Pump Therapy: A Patient Experience Analysis.
作者信息
Deeb Asma, Ziaullah Mishail, Akle Mariette, Strauss Kenneth
机构信息
1 Pediatric Endocrinology Department, Mafraq Hospital, Abu Dhabi, United Arab Emirates.
2 BD Diabetes Care, Erembodegem, Belgium.
出版信息
J Diabetes Sci Technol. 2019 Jan;13(1):146-147. doi: 10.1177/1932296818801361. Epub 2018 Sep 21.
Abstract
摘要
相似文献
1
Utilization and Challenges of Continuous Glucose Monitoring in Sensor-Augmented Pump Therapy: A Patient Experience Analysis.
J Diabetes Sci Technol. 2019 Jan;13(1):146-147. doi: 10.1177/1932296818801361. Epub 2018 Sep 21.
2
Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Diabetes Res Clin Pract. 2019 Jun;152:111-118. doi: 10.1016/j.diabres.2019.05.015. Epub 2019 May 21.
3
HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
J Diabetes Sci Technol. 2015 May;9(3):651-62. doi: 10.1177/1932296815575999. Epub 2015 Mar 9.
4
Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.
Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28.
5
Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes.
Front Endocrinol (Lausanne). 2021 Sep 7;12:722123. doi: 10.3389/fendo.2021.722123. eCollection 2021.
6
"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Diabetes Technol Ther. 2017 Mar;19(3):173-182. doi: 10.1089/dia.2016.0349. Epub 2017 Jan 18.
7
A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
Value Health. 2014 Jul;17(5):561-9. doi: 10.1016/j.jval.2014.05.008. Epub 2014 Jul 15.
8
Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
Diabetes Technol Ther. 2018 Nov;20(11):738-743. doi: 10.1089/dia.2018.0199. Epub 2018 Sep 25.
9
Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
Arch Pediatr. 2019 Feb;26(2):95-101. doi: 10.1016/j.arcped.2018.11.010. Epub 2019 Jan 12.
10
The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy.
J Diabetes Sci Technol. 2018 Nov;12(6):1241-1243. doi: 10.1177/1932296818791536. Epub 2018 Jul 30.
引用本文的文献
1
Integrating health geography and behavioral economic principles to strengthen context-specific behavior change interventions.
Transl Behav Med. 2024 Apr 29;14(5):257-272. doi: 10.1093/tbm/ibad065.
2
Trending Technology of Glucose Monitoring during COVID-19 Pandemic: Challenges in Personalized Healthcare.
Adv Mater Technol. 2021 Sep;6(9):2100020. doi: 10.1002/admt.202100020. Epub 2021 May 6.
本文引用的文献
1
Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization.
J Diabetes Sci Technol. 2017 May;11(3):522-528. doi: 10.1177/1932296817693253. Epub 2017 Feb 1.
2
Limitations of Continuous Glucose Monitor Usage.
Diabetes Technol Ther. 2016 Mar;18(3):115-7. doi: 10.1089/dia.2016.0011.
3
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.
Diabetes Care. 2014 Oct;37(10):2702-9. doi: 10.2337/dc14-0303. Epub 2014 Jul 10.
4
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.
Diabetologia. 2012 Dec;55(12):3155-62. doi: 10.1007/s00125-012-2708-9. Epub 2012 Sep 11.
5
Psychosocial factors and adherence to continuous glucose monitoring in type 1 diabetes.
J Diabetes Sci Technol. 2012 Jul 1;6(4):986-7. doi: 10.1177/193229681200600434.
6
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.
N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853. Epub 2010 Jun 29.
Zotero 插件